B. J. Hanson

发表

Lung CD103+ Dendritic Cells Efficiently Transport Influenza Virus to the Lymph Node and Load Viral Antigen onto MHC Class I for Presentation to CD8 T Cells

P. MacAry, N. Prabhu, P. Hutchinson, 2011, The Journal of Immunology.

Class I for Presentation to CD 8 T Cells Node and Load Viral Antigen onto MHC Transport Influenza Virus to the Lymph Dendritic Cells Efficiently + Lung CD 103

P. MacAry, N. Prabhu, P. Hutchinson, 2011 .

IDentif.AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

R. Desai, Xianting Ding, D. Ho, 2020, medRxiv.

Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays

B. J. Hanson, Conrad E. Z. Chan, A. H. Chan, 2011, Journal of Immunological Methods.

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection

Subhash G. Vasudevan, S. Vasudevan, E. Ooi, 2011, Proceedings of the National Academy of Sciences.

Virus-specific T lymphocytes home to the skin during natural dengue infection

P. MacAry, A. Wilder-Smith, A. Bertoletti, 2015, Science Translational Medicine.

Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.

Moon Y. F. Tay, S. Vasudevan, M. Y. Tay, 2012, Journal of virological methods.

The use of antibodies in the treatment of infectious diseases.

E. Ooi, B. J. Hanson, C. E. Z. Chan, 2009, Singapore medical journal.

The role of phage display in therapeutic antibody discovery

P. MacAry, B. J. Hanson, Conrad E. Z. Chan, 2014, International immunology.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

J. Connolly, S. Maurer-Stroh, J. Low, 2014, Vaccine.

Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza

J. Kwang, N. Prabhu, Fang He, 2009, Antiviral therapy.

Label-free electronic detection of bio-toxins using aligned carbon nanotubes.

B. Liedberg, S. Moochhala, S. Mhaisalkar, 2013, Biosensors & bioelectronics.

Phage Display Approaches for the Isolation of Monoclonal Antibodies Against Dengue Virus Envelope Domain III from Human and Mouse Derived Libraries

Moon Y. F. Tay, S. Vasudevan, M. Y. Tay, 2012, International journal of molecular sciences.

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

B. Au, J. Connolly, J. Low, 2018, Scientific Reports.

Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.

Jianzhu Chen, P. MacAry, B. J. Hanson, 2016, Blood.

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

Jhin Jieh Lim, R. Desai, Xianting Ding, 2020, Bioengineering & translational medicine.

Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis[S]

P. MacAry, A. Cazenave-Gassiot, M. Wenk, 2013, Journal of Lipid Research.

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

D. Lye, B. J. Hanson, S. G. Seah, 2022, Infectious Diseases and Therapy.

Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells

P. MacAry, Jinhua Lu, B. J. Hanson, 2017, npj Vaccines.

Generation and Characterization of a Novel Recombinant Antibody Against 15-Ketocholestane Isolated by Phage-Display

P. MacAry, A. Cazenave-Gassiot, M. Wenk, 2012, International journal of molecular sciences.

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

John E. Connolly, D. Lye, B. J. Hanson, 2022, Infectious Diseases and Therapy.

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01

P. MacAry, J. Lescar, K. Wood, 2019, Nature Communications.

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza

M. Salvatore, B. J. Hanson, Jianjun Yang, 2020, Viruses.

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

B. Au, J. Connolly, Bernett Lee, 2013, PloS one.

The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis

P. MacAry, M. Wenk, P. Seeberger, 2015, Scientific Reports.

Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia

C. Craik, S. Maurer-Stroh, Yifan Cheng, 2021, Cell.

Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue

J. Connolly, Manoj N. Krishnan, S. Lok, 2014, Proceedings of the National Academy of Sciences.

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors

E. Ooi, H. Tan, S. Zhang, 2013, PloS one.

Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization

C. Craik, S. Maurer-Stroh, Yifan Cheng, 2020, bioRxiv.

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

C. Poh, L. Rénia, L. Ng, 2020, Nature Communications.

TCR–like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus–transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants

P. MacAry, B. J. Hanson, S. Chan, 2017, Scientific Reports.

Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection

Kenneth G. C. Smith, P. MacAry, A. Bertoletti, 2012, Journal of Virology.

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

C. Poh, L. Rénia, L. Ng, 2020, Nature Communications.

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library

E. Ooi, B. J. Hanson, Conrad E. Z. Chan, 2008, Virology Journal.

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1

E. Ooi, B. J. Hanson, Conrad E. Z. Chan, 2008, Virology Journal.

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

R. Webby, E. Ooi, B. J. Hanson, 2006, Respiratory research.

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

A. Barrett, P. MacAry, P. Hutchinson, 2020, bioRxiv.

The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody

Kenneth G. C. Smith, M. Ng, V. Kostyuchenko, 2012, Science Translational Medicine.

A simple method for Alexa Fluor dye labelling of dengue virus.

E. Ooi, H. Tan, S. Zhang, 2010, Journal of virological methods.

Teoh by a Human Antibody The Structural Basis for Serotype-Specific Neutralization of Dengue Virus

Kenneth G. C. Smith, M. Ng, V. Kostyuchenko, 2012 .

Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.

D. Gubler, S. Vasudevan, E. Ooi, 2011, Bioscience reports.